IONIC SILICONE HYDROGELS

• US 20130217620A1
• Filed: 03/14/2013
• Published: 08/22/2013
• Est. Priority Date: 12/23/2011
• Status: Active Grant

• Current Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Original Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Inventors: Alli, Azaam, Ford, James D., Vanderlaan, Douglas G., Joslin, Scott L., Mahadevan, Shivkumar, Maggio, Thomas L., Raja, Ranganath, Muthukrishnan, Sharmila, Surendran, C.
• Granted Patent: US 9,125,808 B2
• Time in Patent Office: Days
• US Class Current: 514/2.9
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants
• CPC Class Codes: C08G 77/16 to hydroxyl groups
• CPC Class Codes: C08L 101/14 the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
• CPC Class Codes: C08L 83/04 Polysiloxanes
• CPC Class Codes: G02B 1/043 Contact lenses

Abstract

The present invention relates to ionic silicone hydrogel contact lenses which comprise at least one pharmaceutical or nutriceutical component and are formed from reaction mixtures comprising a mixture of slow-reacting hydrophilic monomers, including at least one slow-reacting ionic monomer, at least one silicone-containing component and at least one hydroxyl-containing component, wherein the ratio of the slow-reacting hydrophilic component half lives to the silicone-containing component half life is at least 2.

Claims

1. A silicone hydrogel comprising at least one pharmaceutical or nutriceutical component wherein said silicone hydrogel is formed from a reaction mixture comprising

about 37 to about 75 wt % of a mixture of slow-reacting hydrophilic monomers, each having a slow-reacting hydrophilic monomer kinetic half life;

said mixture of slow reacting hydrophilic monomers comprising and least one slow-reacting ionic monomer;

at least one silicone-containing component having a silicone-containing component kinetic half life, which may be optionally substituted with at least one hydroxyl containing group; and

at least one hydroxyl-containing component selected from said silicone-containing components substituted with at least one hydroxyl containing group, at least one hydroxyalkyl monomer, and mixtures thereof,

wherein ratio of each of said slow-reacting hydrophilic component half lives to said silicone-containing component half life is at least 2.

2. The silicone hydrogel of claim 1 wherein said slow-reacting ionic component is selected from the group consisting of anionic components, cationic components, zwitterionic components and mixtures thereof.

3. The silicone hydrogel of claim 1 wherein said slow-reacting ionic component comprise at least one anionic component selected from the group consisting of carboxylic acids, sulfonic acids, boronic acids, phosphonic acids and their salts and mixtures thereof.

4. The silicone hydrogel of claim 1 wherein said slow-reacting ionic component comprises reactive functionality selected from the group consisting of ionic vinyl ethers, ionic vinyl amines and ionic vinyl enamines.

5. The silicone hydrogel of claim 1 wherein said slow-reacting ionic component is selected from the group consisting of 4-acrylamidobutanoic acid (ACAII), (3-acrylamidophenyl)boronic acid (APBA), 3-acrylamidopropionic acid, 5-acrylamidopentanoic acid, 3-acrylamido-3-methylbutanoic acid (AMBA), N-vinyloxycarbonyl-α

-alanine, N-vinyloxycarbonyl-β

-alanine (VINAL), 2-vinyl-4,4-dimethyl-2-oxazolin-5-one (VDMO), vinyl sulphonate salt, 3-((3-acrylamidopropyl)dimethylammonio)propane-1-sulfonate (AMPDAPS), 3-((3-methacrylamidopropyl)dimethylammonio)propane-1-sulfonate (MAMPDAPS);

acetic acid, 2-carboxymethoxy)-, 1-ethenylester, of Formula

6. The silicone hydrogel of claim 1 wherein said slow-reacting ionic component is selected from the group consisting of N-vinyloxycarbonyl-α

-alanine;

N-vinyloxycarbonyl-β

-alanine (VINAL);

2-vinyl-4,4-dimethyl-2-oxazolin-5-one (VDMO);

vinyl sulphonate sodium salt;

acetic acid, 2-carboxymethoxy)-, 1-ethenylesters of Formula Q, mixtures thereof and the like.

7. The silicone hydrogel of claim 1-4 wherein said slow-reacting ionic component is present in the reactive mixture in an amount below about 20 mole %.

8. The silicone hydrogel of claim 1-4 wherein said slow-reacting ionic component is present in the reactive mixture in an amount between about 0.5 and about 15 mole %, based upon all components in the reaction mixture.

9. The silicone hydrogel of claim 1-4 wherein said slow-reacting ionic component is present in the reactive mixture in an amount between about 0.5 and about 5 mole %, based upon all components in the reaction mixture.

10. The silicone hydrogel of claim 1-4 wherein said slow-reacting ionic component is present in the reactive mixture in an amount between about 0.5 and about 10 mole %, based upon all components in the reaction mixture.

11. The silicone hydrogel of claim 1 wherein all of said slow-reacting components have the same reactive functionality.

12. The silicone hydrogel of claim 1 wherein all of said slow-reacting components have vinyl functionality.

13. The silicone hydrogel of claim 1 wherein said reaction mixture further comprises at least one slow reacting crosslinker and at least one fast reacting crosslinker.

14. The silicone hydrogel of claim 13 wherein said slow reacting crosslinkers have only vinyl reactive functionality and said fast reacting crosslinkers have (meth)acrylate reactive functionality only.

15. The silicone hydrogel of claim 13 wherein said slow reacting crosslinker comprises TAC and said fast reacting crosslinker is selected from the group consisting of EDGMA, TEGDMA and mixtures thereof.

16. The silicone hydrogel of claim 13 wherein said at least one slow reacting crosslinker and at least one fast reacting crosslinker are each present in said reaction mixture in amounts between about 0.4 to about 2.0 mmoles per 100 g of reactive components.

17. The silicone hydrogel of claim 13 wherein said at least one slow reacting crosslinker and at least one fast reacting crosslinker are each present in said reaction mixture in amounts between about 0.3 to about 2.0 mmol/100 g of polymerizable components

18. The silicone hydrogel of claim 1 wherein said reactive mixture further comprises at least one reactive cationic component.

19. The silicone hydrogel of claim 18 wherein said cationic component or hydrogen bonding component is present in an amount sufficient to improve surface resilience of said hydrogel.

20. The silicone hydrogel of claim 18 wherein said at least one reactive cationic component has the same reactive functionality as at least one of said silicone containing components.

21. The silicone hydrogel of claim 1 wherein said kinetic half life ratio is at least about 3.

22. The silicone hydrogel of claim 1 further comprising a Dk of at least about 80.

23. The silicone hydrogel of claim 1 further comprising a Dk of at least about 85.

24. The silicone hydrogel of claim 1 further comprising a % haze of less than about 70%.

25. The silicone hydrogel of claim 1 further comprising a % haze of less than about 50%.

26. The silicone hydrogel of claim 1 further comprising a water content of at least about 55%.

27. The silicone hydrogel of claim 1 further comprising a water content of at least about 60%.

28. The silicone hydrogel of claim 1 further comprising a modulus of less than about 150 psi.

29. The silicone hydrogel of claim 1 further comprising a modulus of about 100 psi or less.

30. The silicone hydrogel of claim 1 wherein said reaction mixture further comprises at least one UV absorbing compound.

31. The silicone hydrogel of claim 13 wherein said at least one UV absorbing compound is reactive.

32. The silicone hydrogel of claim 13 wherein said at least one UV absorbing compound is selected from benzotriazoles.

33. The silicone hydrogel of claim 13 wherein said at least one UV absorbing compound is selected from the group consisting of reactive 2-(2′

-hydroxyphenyl)benzotriazoles, 2-hydroxybenzophenones, 2-hydroxyphenyltriazines, oxanilides, cyanoacrylates, salicylates and 4-hydroxybenzoates.

34. The silicone hydrogel of claim 13 wherein said at least one UV absorbing compound is selected from the group consisting of 2-(2′

-hydroxy-5-methacrylyloxyethylphenyl)-2H-benzotriazole, 5-vinyl and 5-isopropenyl derivatives of 2-(2,4-dihydroxyphenyl)-2H-benzotriazole and 4-acrylates or 4-methacrylates of 2-(2,4-dihydroxyphenyl)-2H-benzotriazole or 2-(2,4-dihydroxyphenyl)-1,3-2H-dibenzotriazole, and mixtures thereof.

35. The silicone hydrogel of claim 13 comprising between about 0.5 and about 4 wt. %, of at least one UV absorber.

36. The silicone hydrogel of claim 13 comprising between about 1 wt % and about 2 wt % UV absorber.

37. The silicone hydrogel of claim 1 wherein said reaction mixture is substantially free of diluent.

38. The silicone hydrogel of claim 1 wherein said reaction mixture is substantially free of TRIS.

39. The silicone hydrogel of claim 1 wherein said slow-reacting hydrophilic monomer comprises a reactive group selected from the group consisting of (meth)acrylamides, vinyls, allyls and combinations thereof and said silicone-containing component comprises a reactive group selected from the group consisting of (meth)acrylates, styryls, amides and mixtures thereof.

40. The silicone hydrogel of claim 1 wherein said slow-reacting hydrophilic monomer comprises a reactive group selected from the group consisting of vinyls, allyls and combinations thereof and said silicone-containing component comprises a reactive group selected from the group consisting of (meth)acrylates, styryls, amides and mixtures thereof.

41. The silicone hydrogel of claim 1 wherein said slow-reacting hydrophilic monomer is present in an amount between about 39 and about 70 wt %.

42. The silicone hydrogel of claim 1 wherein said slow-reacting hydrophilic monomer is present in an amount between about 39 and about 60 wt %.

43. The silicone hydrogel of claim 1 wherein said slow-reacting hydrophilic monomer comprises a reactive group selected from the group consisting of N-vinyl amides, O-vinyl carbamates, O-vinyl carbonates, N-vinyl carbamates, O-vinyl ethers, O-2-propenyl, wherein the vinyl or allyl groups may be further substituted with a methyl group.

44. The silicone hydrogel of claim 1 wherein said slow reacting hydrophilic monomer comprises at least one hydrophilic group selected from the group consisting of hydroxyls, amines, ethers, amides, ammonium groups, carboxylic acid, carbamates and combinations thereof.

45. The silicone hydrogel of claim 1 wherein said slow reacting hydrophilic monomer comprises at least one hydrophilic group selected from the group consisting of hydroxyls, ethers, amides, carboxylic acid combinations thereof.

46. The silicone hydrogel of claim 1 wherein said slow reacting hydrophilic monomer is selected from N-vinylamide monomer of Formula I, a vinyl pyrrolidone of Formula II-IV, n-vinyl piperidone of Formula V:

47. The silicone hydrogel of claim 46 wherein the slow-reacting hydrophilic monomer is selected from the vinyl pyrrolidone of Formula II or IV or the N-vinyl amide monomer of Formula I, and the total number of carbon atoms in R₁ and R₂ is 4 or less.

48. The silicone hydrogel of claim 46 wherein the slow-reacting hydrophilic monomer is selected from a vinyl pyrrolidone of Formula III or IV and R₆ is methyl, R₇ is hydrogen, R₉ is CH═

CH₂, R₁₀ and R₁₁ are H.

49. The silicone hydrogel of claim 1 wherein the slow-reacting hydrophilic monomer is selected from the slow-reacting hydrophilic monomer is selected from ethylene glycol vinyl ether (EGVE), di(ethylene glycol) vinyl ether (DEGVE), N-vinyl pyrrolidone (NVP), 1-methyl-3-methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone;

1-ethyl-5-methylene-2-pyrrolidone, N-methyl-3-methylene-2-pyrrolidone, 5-ethyl-3-methylene-2-pyrrolidone, 1-n-propyl-3-methylene-2-pyrrolidone, 1-n-propyl-5-methylene-2-pyrrolidone, 1-isopropyl-3-methylene-2-pyrrolidone, 1-isopropyl-5-methylene-2-pyrrolidone, N-vinyl-N-methyl acetamide (VMA), N-vinyl-N-ethyl acetamide, N-vinyl-N-ethyl formamide, N-vinyl formamide, N-vinyl acetamide, N-vinyl isopropylamide, allyl alcohol, N-vinyl caprolactam, N-2-hydroxyethyl vinyl carbamate, N-carboxy-β

-alanine N-vinyl ester;

N-carboxyvinyl-β

-alanine (VINAL), N-carboxyvinyl-α

-alanine and mixtures thereof.

50. The silicone hydrogel of claim 1 wherein the slow-reacting hydrophilic monomer is selected from NVP, VMA and 1-methyl-5-methylene-2-pyrrolidone.

51. The silicone hydrogel of claim 1 wherein the slow-reacting hydrophilic monomer comprises NVP.

52. The silicone hydrogel of claim 1 wherein said silicone-containing component comprises at least one hydroxyl group.

53. The silicone hydrogel of claim 1 further comprising at least one hydroxyalkyl monomer.

54. The silicone hydrogel of claim 53 wherein said hydroxyalkyl monomer is selected from hydroxyalkyl (meth)acrylate or (meth)acrylamide monomer of Formula VII or a styryl compound of Formula VIII

55. The silicone hydrogel of claim 53 wherein R₁ is H or methyl, X is oxygen and R is selected from C₂-C₄ mono or dihydroxy substituted alkyl, and poly(ethylene glycol) having 1-10 repeating units.

56. The silicone hydrogel of claim 53 wherein R₁ methyl, X is oxygen and R is selected from C₂-C₄ mono or dihydroxy substituted alkyl, and poly(ethylene glycol) having 2-20 repeating units.

57. The silicone hydrogel of claim 53 wherein said hydroxyalkyl monomer is selected from 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 1-hydroxypropyl-2-(meth)acrylate, 2-hydroxy-2-methyl-propyl (meth)acrylate, 3-hydroxy-2,2-dimethyl-propyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, glycerol (meth)acrylate, 2-hydroxyethyl (meth)acrylamide, polyethyleneglycol monomethacrylate, bis-(2-hydroxyethyl) (meth)acrylamide, 2,3-dihydroxypropyl (meth)acrylamide, and mixtures thereof.

58. The silicone hydrogel of claim 53 wherein said hydroxyalkyl monomer is selected from the group consisting of 2-hydroxyethyl methacrylate, glycerol methacrylate, 2-hydroxypropyl methacrylate, hydroxybutyl methacrylate, 3-hydroxy-2,2-dimethyl-propyl methacrylate, and mixtures thereof.

59. The silicone hydrogel of claim 53 wherein said hydroxyalkyl monomer comprises 2-hydroxyethyl methacrylate, 3-hydroxy-2,2-dimethyl-propyl methacrylate, glycerol methacrylate and mixtures comprising them.

60. The silicone hydrogel of claim 1 wherein the at least one silicone-containing monomer is monofunctional and comprises (a) a reactive group selected from (meth)acrylates, styryls, amides and mixtures thereof and (b) a polydialkyl siloxane chain and may optionally contain fluorine.

61. The silicone hydrogel of claim 1 wherein said silicone-containing component is selected from mono (meth)acryloxyalkyl polydialkylsiloxane monomer of Formula IX or the styryl polydialkylsiloxane monomer of Formula X:

62. The silicone hydrogel of claim 61 wherein each R₁₄ is independently selected from ethyl and methyl groups.

63. The silicone hydrogel of claim 61 wherein all R₁₄ are methyl.

64. The silicone hydrogel of claim 61 wherein R₁₂ and each R₁₄ are methyl.

65. The silicone hydrogel of claim 61 wherein at least one R₁₄ is 3,3,3-trifluoropropyl.

66. The silicone hydrogel of claim 61 wherein R₁₃ is selected from C1-C6 alkylene groups which may be substituted with ether, hydroxyl and combinations thereof.

67. The silicone hydrogel of claim 61 wherein R₁₃ is selected from C1 or C3-C6 alkylene groups which may be substituted with ether, hydroxyl and combinations thereof.

68. The silicone hydrogel of claim 61 wherein a is 5 to 15

69. The silicone hydrogel of claim 61 wherein R₁₆ is H or methyl.

70. The silicone hydrogel of claim 61 wherein said monomethacryloxyalkylpolydimethylsiloxane methacrylate is selected from the group consisting of monomethacryloxypropyl terminated mono-n-butyl terminated polydimethylsiloxane, monomethacryloxypropyl terminated mono-n-methyl terminated polydimethylsiloxane, monomethacryloxypropyl terminated mono-n-butyl terminated polydiethylsiloxane, monomethacryloxypropyl terminated mono-n-methyl terminated polydiethylsiloxane, N-(2,3-dihydroxypropane)-N′

-(propyl tetra(dimethylsiloxy)dimethylbutylsilane)acrylamide, α

-(2-hydroxy-1-methacryloxypropyloxypropyl)-ω

-butyl-octamethylpentasiloxane, and mixtures thereof.

71. The silicone hydrogel of claim 61 wherein said monomethacryloxyalkylpolydimethylsiloxane methacrylate is selected from the group consisting of monomethacryloxypropyl terminated mono-n-butyl terminated polydimethylsiloxane, monomethacryloxypropyl terminated mono-n-methyl terminated polydimethylsiloxane, N-(2,3-dihydroxypropane)-N′

-(propyl tetra(dimethylsiloxy)dimethylbutylsilane)acrylamide, and mixtures thereof.

72. The silicone hydrogel of claim 1 further comprising at least one crosslinking monomer.

73. The silicone hydrogel of claim 1 wherein further comprising at least one photoinitiator.

74. The silicone hydrogel of claim 1 further comprising an advancing contact angle of less than about 80°

.

75. The silicone hydrogel of claim 1 further comprising an advancing contact angle of less than about 70°

.

76. The silicone hydrogel of claim 1 further comprising from about 5 to about 20 wt % of at least one polar diluent, based upon all components in the reaction mixture.

77. The silicone hydrogel of claim 1 wherein said reaction mixture further comprises at least one slow reacting crosslinker and at least one fast reacting crosslinker.

78. The silicone hydrogel of claim 77 wherein said slow reacting crosslinkers have only vinyl reactive functionality and said fast reacting crosslinkers have (meth)acrylate reactive functionality only.

79. The silicone hydrogel of claim 77 wherein said slow reacting crosslinker comprises TAC and said fast reacting crosslinker is selected from the group consisting of EDGMA, TEGDMA and mixtures thereof.

80. The silicone hydrogel of claim 1 wherein said reaction mixture comprises less than about 5% of intermediate reacting hydrophilic components.

81. The silicone hydrogel of claim 77 wherein said at least one slow reacting crosslinker and at least one fast reacting crosslinker are each present in said reaction mixture in amounts between about 0.05 to about 0.3 wt %.

82. The silicone hydrogel of claim 77 wherein said at least one slow reacting crosslinker and at least one fast reacting crosslinker are each present in said reaction mixture in amounts between about 0.1 to about 0.2 wt %.

83. The silicone hydrogel of claim 77 wherein all crosslinkers are present in an amount less than about 0.5 wt %.

84. The contact lens of claim 1 wherein said at least one pharmaceutical pharmaceutical or neutraceutical component is cationic.

85. The contact lens of claim 1 wherein said at least one pharmaceutical pharmaceutical or neutraceutical component is selected from the group consisting of atropine, pirenzepine, doxycycline, brimonidine, brinzolamide, dorzolamide, betaxolol, apraclonidine, ccr2 antagonist, olopatadine, alcaftadine, betaxolol, bupivacaine, carbachol, carteolol, chlortetracycline, cyclopentolate, dibutoline, dipivefrin, ephedrine, erythromycin, gentamycin, gramicidin, homatropine ketotifen, levobunolol, levocabastine, lidocaine, lignocaine, lomefloxacin, mepivacaine, naphazoline, neomycin, ofloxacin, oxybuprocaine, pheniramine, physostigmine, pilocarpine, polymyxin B, proparacaine, pyrilamine, tetracaine, tetracycline, tetrahydrozoline, timolol, tropicamide, vidarabine, pharmaceutically acceptable salts thereof and combinations thereof and the like.

86. The contact lens of claim 1 wherein said at least one pharmaceutical pharmaceutical or neutraceutical component is selected from the group consisting of atropine, pirenzepine, doxycycline, brimonidine, brinzolamide, dorzolamide, betaxolol, apraclonidine, ccr2 antagonist, olopatadine, alcaftadine, betaxolol, bupivacaine, carbachol, carteolol, chlortetracycline, cyclopentolate, dibutoline, dipivefrin, erythromycin, gentamycin, gramicidin, homatropine ketotifen, levobunolol, levocabastine, lidocaine, lignocaine, lomefloxacin, mepivacaine, naphazoline, ofloxacin, pheniramine, physostigmine, pilocarpine, polymyxin B, proparacaine, pyrilamine, tetracaine, tetrahydrozoline, timolol, tropicamide pharmaceutically acceptable salts thereof and combinations thereof and the like.

87. The contact lens of claim 1 wherein said at least one pharmaceutical pharmaceutical or nutraceutical component is selected from the group consisting of atropine, ketotifen, olopatadine, alcaftadine, levocabastine, pirenzepine, doxycycline, brimonidine, brinzolamide, dorzolamide, betaxolol, apraclonidine, ccr2 antagonist, olopatadine pharmaceutically acceptable salts thereof and combinations thereof and the like.

88. The contact lens of claim 1, 85, 86 or 87, wherein said at least one pharmaceutical or nutraceutical component in a symptom mitigating effective amount.

89. The contact lens of claim 88 wherein said symptom mitigating effective amount is between about 5 μ

g and about less than 200 μ

g.

90. The contact lens of claim 88 wherein said symptom mitigating effective amount is between about 9 μ

g and about 100 μ

g.

91. The contact lens of claim 88 wherein said symptom mitigating effective amount alleviates symptoms for between about 5 minutes, and about 12 hours from insertion of said contact lens on a human'"'"'s eye.

92. The contact lens of claim 1 wherein said contact lens comprises a modulus which increases less than about 30% after three autoclave cycles.